Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism IRAK4 inhibitors(Interleukin-1 receptor-associated kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H24FN5O2S |
InChIKeySHENXRCDBJGWNU-GOSISDBHSA-N |
CAS Registry1610016-88-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Phase 1 | - | - |